Cytokinetics, Incorporated (CYTK)
USD 37.35
(-12.98%)
USD 37.35
(-12.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -322.59 Million USD | 97.02% |
| 2022 | -146.22 Million USD | -63.36% |
| 2021 | -89.51 Million USD | -117.66% |
| 2020 | -41.12 Million USD | 30.6% |
| 2019 | -59.25 Million USD | -2.82% |
| 2018 | -57.63 Million USD | 25.08% |
| 2017 | -76.92 Million USD | -265.4% |
| 2016 | 46.51 Million USD | 362.18% |
| 2015 | -17.74 Million USD | -805.65% |
| 2014 | 2.51 Million USD | 113.37% |
| 2013 | -18.8 Million USD | 31.48% |
| 2012 | -27.44 Million USD | -786.03% |
| 2011 | 4 Million USD | 55.22% |
| 2010 | 2.57 Million USD | -96.84% |
| 2009 | 81.53 Million USD | 556.51% |
| 2008 | 12.42 Million USD | -8.82% |
| 2007 | 13.62 Million USD | 335.63% |
| 2006 | 3.12 Million USD | -64.91% |
| 2005 | 8.91 Million USD | -33.7% |
| 2004 | 13.44 Million USD | 27.09% |
| 2003 | 10.57 Million USD | -7.19% |
| 2002 | 11.39 Million USD | 34.61% |
| 2001 | 8.46 Million USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -1.49 Million USD | 67.92% |
| 2024 Q2 | -2.15 Million USD | -44.18% |
| 2023 Q2 | -82.32 Million USD | -10.05% |
| 2023 Q1 | -74.8 Million USD | -2.39% |
| 2023 Q4 | -4.66 Million USD | 94.32% |
| 2023 FY | -4.36 Million USD | 97.02% |
| 2023 Q3 | -82.15 Million USD | 0.21% |
| 2022 Q3 | -60.21 Million USD | -289.12% |
| 2022 Q4 | -73.06 Million USD | -21.33% |
| 2022 Q1 | -44.78 Million USD | -470.08% |
| 2022 FY | -146.22 Million USD | -63.36% |
| 2022 Q2 | 31.84 Million USD | 171.1% |
| 2021 Q2 | -33.6 Million USD | -34.33% |
| 2021 Q3 | -42.99 Million USD | -27.97% |
| 2021 Q4 | 12.1 Million USD | 128.14% |
| 2021 FY | -89.51 Million USD | -117.66% |
| 2021 Q1 | -25.01 Million USD | -11.17% |
| 2020 Q2 | -18.19 Million USD | -1.59% |
| 2020 Q3 | 17.48 Million USD | 196.09% |
| 2020 FY | -41.12 Million USD | 30.6% |
| 2020 Q4 | -22.49 Million USD | -228.67% |
| 2020 Q1 | -17.91 Million USD | -36.51% |
| 2019 Q4 | -13.12 Million USD | 7.42% |
| 2019 Q1 | -15.08 Million USD | -8.49% |
| 2019 FY | -59.25 Million USD | -2.82% |
| 2019 Q2 | -16.88 Million USD | -11.93% |
| 2019 Q3 | -14.17 Million USD | 16.03% |
| 2018 Q1 | -16.86 Million USD | 35.79% |
| 2018 Q2 | -15.36 Million USD | 8.89% |
| 2018 Q3 | -10.75 Million USD | 30.04% |
| 2018 Q4 | -13.9 Million USD | -29.31% |
| 2018 FY | -57.63 Million USD | 25.08% |
| 2017 Q2 | -16.75 Million USD | -10.7% |
| 2017 FY | -76.92 Million USD | -265.4% |
| 2017 Q3 | -18.76 Million USD | -12.0% |
| 2017 Q1 | -15.13 Million USD | -205.38% |
| 2017 Q4 | -26.26 Million USD | -39.97% |
| 2016 Q2 | -3.92 Million USD | 23.31% |
| 2016 Q1 | -5.11 Million USD | -46.42% |
| 2016 FY | 46.51 Million USD | 362.18% |
| 2016 Q3 | 39.7 Million USD | 1112.68% |
| 2016 Q4 | 14.36 Million USD | -63.83% |
| 2015 Q4 | -3.49 Million USD | 3.32% |
| 2015 FY | -17.74 Million USD | -805.65% |
| 2015 Q3 | -3.61 Million USD | 40.73% |
| 2015 Q2 | -6.09 Million USD | -34.17% |
| 2015 Q1 | -4.54 Million USD | -134.99% |
| 2014 Q3 | -2 Million USD | 49.23% |
| 2014 Q4 | 12.97 Million USD | 747.33% |
| 2014 Q1 | -4.51 Million USD | -142.86% |
| 2014 FY | 2.51 Million USD | 113.37% |
| 2014 Q2 | -3.94 Million USD | 12.46% |
| 2013 Q3 | -8.97 Million USD | 20.83% |
| 2013 FY | -18.8 Million USD | 31.48% |
| 2013 Q4 | 10.52 Million USD | 217.26% |
| 2013 Q2 | -11.33 Million USD | -25.8% |
| 2013 Q1 | -9.01 Million USD | -28.21% |
| 2012 Q3 | -7.08 Million USD | -484.79% |
| 2012 Q4 | -7.03 Million USD | 0.76% |
| 2012 FY | -27.44 Million USD | -786.03% |
| 2012 Q1 | 1.82 Million USD | 140.42% |
| 2012 Q2 | 1.84 Million USD | 1.15% |
| 2011 Q1 | 763 Thousand USD | -30.57% |
| 2011 Q2 | 1.05 Million USD | 38.01% |
| 2011 Q3 | 1.42 Million USD | 35.52% |
| 2011 Q4 | 757 Thousand USD | -46.95% |
| 2011 FY | 4 Million USD | 55.22% |
| 2010 Q4 | 1.09 Million USD | 178.93% |
| 2010 FY | 2.57 Million USD | -96.84% |
| 2010 Q1 | 621 Thousand USD | -39.3% |
| 2010 Q2 | 462 Thousand USD | -25.6% |
| 2010 Q3 | 394 Thousand USD | -14.72% |
| 2009 Q3 | 5.5 Million USD | -92.35% |
| 2009 Q4 | 1.02 Million USD | -81.42% |
| 2009 FY | 81.53 Million USD | 556.51% |
| 2009 Q1 | 3.07 Million USD | -2.35% |
| 2009 Q2 | 71.93 Million USD | 2236.91% |
| 2008 Q3 | 3.12 Million USD | 1.66% |
| 2008 Q1 | 3.06 Million USD | -1.32% |
| 2008 FY | 12.42 Million USD | -8.82% |
| 2008 Q4 | 3.15 Million USD | 0.86% |
| 2008 Q2 | 3.07 Million USD | 0.16% |
| 2007 FY | 13.62 Million USD | 335.63% |
| 2007 Q4 | 3.11 Million USD | -24.7% |
| 2007 Q3 | 4.13 Million USD | 30.0% |
| 2007 Q2 | 3.17 Million USD | -0.87% |
| 2007 Q1 | 3.2 Million USD | 1967.74% |
| 2006 Q1 | 1.42 Million USD | -33.77% |
| 2006 Q3 | 106 Thousand USD | -92.67% |
| 2006 Q4 | 155 Thousand USD | 46.23% |
| 2006 FY | 3.12 Million USD | -64.91% |
| 2006 Q2 | 1.44 Million USD | 1.83% |
| 2005 Q2 | 2.34 Million USD | -8.98% |
| 2005 Q3 | 1.85 Million USD | -20.76% |
| 2005 FY | 8.91 Million USD | -33.7% |
| 2005 Q4 | 2.14 Million USD | 15.58% |
| 2005 Q1 | 2.57 Million USD | 15.54% |
| 2004 Q2 | 2.9 Million USD | -50.57% |
| 2004 Q3 | 2.44 Million USD | -15.55% |
| 2004 Q1 | 5.86 Million USD | 121.9% |
| 2004 Q4 | 2.22 Million USD | -9.11% |
| 2004 FY | 13.44 Million USD | 27.09% |
| 2003 Q1 | 2.74 Million USD | 0.0% |
| 2003 FY | 10.57 Million USD | -7.19% |
| 2003 Q4 | 2.64 Million USD | 0.0% |
| 2003 Q3 | 2.64 Million USD | 3.52% |
| 2003 Q2 | 2.55 Million USD | -7.09% |
| 2002 FY | 11.39 Million USD | 34.61% |
| 2001 FY | 8.46 Million USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | -670.85% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 440.565% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 121.253% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -635676.508% |
| Apollomics, Inc. | 127 Thousand USD | 254110.236% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -305168.985% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -1402478.261% |
| Bicycle Therapeutics plc | -129.52 Million USD | -149.068% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 40323.566% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 268927.5% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 1708.782% |
| Chimerix, Inc. | 324 Thousand USD | 99665.741% |
| CRISPR Therapeutics AG | 240.95 Million USD | 233.88% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 747.712% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 879.474% |
| Fortress Biotech, Inc. | 57.85 Million USD | 657.608% |
| Fortress Biotech, Inc. | 57.85 Million USD | 657.608% |
| Gritstone bio, Inc. | -6.26 Million USD | -5053.243% |
| Allakos Inc. | -6.14 Million USD | -5153.102% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -33608.777% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 2280.566% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -184238.857% |
| Innoviva, Inc. | 261.06 Million USD | 223.568% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -2827678.752% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -8984.568% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -3209461.238% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -36516.686% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -80750.376% |
| ImmuCell Corporation | 4.39 Million USD | 7437.856% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -203.98% |
| Incyte Corporation | 3.44 Billion USD | 109.376% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -11975.224% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 165780.403% |
| Mustang Bio, Inc. | -2.22 Million USD | -14398.562% |
| MiMedx Group, Inc. | 266.84 Million USD | 220.892% |
| MEI Pharma, Inc. | 49.32 Million USD | 753.989% |
| MacroGenics, Inc. | 50.52 Million USD | 738.457% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | 4444.102% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -4439.947% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 1210.284% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 330.092% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -1041127.164% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -332470.103% |
| NextCure, Inc. | -3.68 Million USD | -8656.596% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 12632.751% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 1794.024% |
| Onconetix, Inc. | -1.12 Million USD | -28519.856% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -1013.618% |
| Opthea Limited | 21.72 Thousand USD | 1485334.807% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -26673.87% |
| Psyence Biomedical Ltd. | -240.00 USD | -134413650.0% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -562634.187% |
| Precigen, Inc. | 106 Thousand USD | 304433.019% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 32071.556% |
| Prime Medicine, Inc. | -147.9 Million USD | -118.108% |
| PureTech Health plc | -1.6 Million USD | -20024.329% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -4444.844% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 102.854% |
| Replimune Group, Inc. | -2.65 Million USD | -12050.395% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1287747.818% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 393.875% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -62327.769% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 19.284% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 906.483% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -611.733% |
| Solid Biosciences Inc. | -76.56 Million USD | -321.343% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -2688175.0% |
| SciSparc Ltd. | 2.19 Million USD | 14790.027% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -1108.485% |
| TG Therapeutics, Inc. | 219.1 Million USD | 247.23% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 10757.185% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -18557.779% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 341.123% |
| UroGen Pharma Ltd. | 73.35 Million USD | 539.788% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 7468.502% |
| XOMA Corporation | 3.86 Million USD | 8455.167% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -23124.838% |
| AbCellera Biologics Inc. | 38.02 Million USD | 948.371% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -6451760.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | -260.749% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -935.025% |
| Precision BioSciences, Inc. | 40.47 Million USD | 897.077% |
| Dyadic International, Inc. | 922.95 Thousand USD | 35052.116% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -219351.02% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 1631.708% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 76183.255% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -3613.514% |
| IGM Biosciences, Inc. | -211.66 Million USD | -52.411% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -16061.974% |
| Acelyrin, Inc. | -115 Thousand USD | -280415.652% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 13348.172% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 369.382% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -2315.007% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 308.406% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -228.449% |
| Senti Biosciences, Inc. | -2.68 Million USD | -11923.593% |
| Mesoblast Limited | -9.81 Million USD | -3186.735% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -191.968% |
| ChromaDex Corporation | 50.78 Million USD | 735.276% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 367.77% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 4690.764% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 338.483% |
| Novavax, Inc. | 639.93 Million USD | 150.41% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -228.63% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -642.224% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 248248.462% |
| Celcuity Inc. | -142.77 Thousand USD | -225849.766% |
| ContextLogic Inc. | 59 Million USD | 646.768% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 62739.417% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 2046.028% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 109.492% |
| Amarin Corporation plc | 165.54 Million USD | 294.872% |
| AnaptysBio, Inc. | 14.78 Million USD | 2282.484% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -56794.709% |
| Aptorum Group Limited | -1.11 Million USD | -28840.206% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 1419.345% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 234.003% |
| Ardelyx, Inc. | 106.66 Million USD | 402.447% |
| Celularity Inc. | 6.75 Million USD | 4875.618% |
| Omeros Corporation | -69.77 Million USD | -362.307% |
| Humacyte, Inc. | -76.55 Million USD | -321.415% |
| Immunocore Holdings plc | 248.39 Million USD | 229.873% |
| IO Biotech, Inc. | -756 Thousand USD | -42571.032% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -22522.23% |
| Summit Therapeutics Inc. | -2.05 Million USD | -15636.244% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -6623.489% |
| Pulmatrix, Inc. | -8.22 Million USD | -3824.489% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 19.108% |
| Evogene Ltd. | 1.39 Million USD | 23158.828% |
| CorMedix Inc. | -205.56 Thousand USD | -156832.215% |
| BioLineRx Ltd. | 1.1 Million USD | 29214.892% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 65138.911% |
| Sagimet Biosciences Inc. | 2 Million USD | 16229.65% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 136.98% |
| scPharmaceuticals Inc. | 9.78 Million USD | 3397.823% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -367.553% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 167.787% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -2827678.752% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -1112289.655% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -170584.127% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 8063.293% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -61346.286% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -729946.619% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -2988.505% |
| Daré Bioscience, Inc. | 2.76 Million USD | 11747.967% |
| bluebird bio, Inc. | -4.03 Million USD | -7904.789% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 116.94% |
| DBV Technologies S.A. | 15.72 Million USD | 2151.075% |
| Avidity Biosciences, Inc. | -181.4 Million USD | -77.827% |
| Galecto, Inc. | -830 Thousand USD | -38766.627% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -56396.147% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -719.95% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 53070.936% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -225015.666% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 690.624% |
| ADMA Biologics, Inc. | 88.21 Million USD | 465.677% |
| Clene Inc. | 533 Thousand USD | 60624.015% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 16327.012% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -67879.433% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -3101755.769% |
| Soligenix, Inc. | 97.31 Thousand USD | 331607.229% |
| Century Therapeutics, Inc. | -10.8 Million USD | -2884.485% |
| Kura Oncology, Inc. | -849 Thousand USD | -37896.82% |
| Surrozen, Inc. | -27.23 Million USD | -1084.697% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -380.736% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 425.723% |
| Autolus Therapeutics plc | -4.86 Million USD | -6528.169% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -191919.643% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -315.723% |
| GRI Bio, Inc. | 10.84 Million USD | 3075.676% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 12800.582% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -588.727% |
| INmune Bio, Inc. | 155 Thousand USD | 208224.516% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 620.824% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -21316.38% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -49648.016% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -4261366.314% |
| Jaguar Health, Inc. | 7.72 Million USD | 4276.502% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -1101877.864% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 80347.015% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 4198.501% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -102964.856% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 441.509% |
| Verastem, Inc. | -62 Thousand USD | -520211.29% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -123498.851% |
| Histogen Inc. | 3.76 Million USD | 8659.114% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 56088.33% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 147.391% |
| Surrozen, Inc. | -27.23 Million USD | -1084.697% |
| Organovo Holdings, Inc. | -5.38 Million USD | -5886.138% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -16292475.758% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 5417.681% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -480442.521% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 221357.202% |
| Kronos Bio, Inc. | 1.37 Million USD | 23612.609% |
| Turnstone Biologics Corp. | 16.5 Million USD | 2054.398% |
| Synaptogenix, Inc. | -6347.00 USD | -5082505.956% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -632435.294% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 1207.463% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 299.915% |
| Exelixis, Inc. | 1.75 Billion USD | 118.354% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -187.616% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 195.419% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -29014.892% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -272151.057% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 4508.212% |
| Insmed Incorporated | 239.63 Million USD | 234.618% |
| MediWound Ltd. | 3.57 Million USD | 9116.015% |
| OmniAb, Inc. | 14.66 Million USD | 2299.448% |
| Alector, Inc. | -95.05 Million USD | -239.382% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 356.799% |
| Zai Lab Limited | 170.9 Million USD | 288.758% |
| AlloVir, Inc. | -398 Thousand USD | -80953.518% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 493.997% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -31159.012% |
| Aura Biosciences, Inc. | -1.29 Million USD | -24810.656% |
| Immunic, Inc. | -111 Thousand USD | -290524.324% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 2134.774% |
| Veracyte, Inc. | 248.14 Million USD | 230.0% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 95.384% |
| FibroGen, Inc. | 128.9 Million USD | 350.258% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 202.844% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -57197240.426% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -2665.031% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 83028.792% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 190.783% |
| Fortrea Holdings Inc. | 424 Million USD | 176.083% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -274.381% |
| XBiotech Inc. | -1.74 Million USD | -18397.305% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -29014.892% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -48483.283% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -594.181% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -327.083% |
| Agenus Inc. | 139.61 Million USD | 331.059% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 539.482% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 2019.854% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 182.92% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -549.773% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 198.727% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -2748.795% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -232.742% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 5974044.444% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -482628.538% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -184404.384% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -86154.813% |
| Ainos, Inc. | -253.73 Thousand USD | -127038.764% |
| Pluri Inc. | 322 Thousand USD | 100284.161% |
| Prothena Corporation plc | -129.2 Million USD | -149.683% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 739.762% |
| Rallybio Corporation | -150 Thousand USD | -214962.0% |
| Kodiak Sciences Inc. | -25.94 Million USD | -1143.277% |
| Cue Biopharma, Inc. | -32.6 Million USD | -889.337% |
| MeiraGTx Holdings plc | 287 Thousand USD | 112501.742% |
| Annexon, Inc. | -3.26 Million USD | -9774.288% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -672.919% |
| Moderna, Inc. | 2.15 Billion USD | 114.97% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -2026.66% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 617.125% |
| Blueprint Medicines Corporation | 236.58 Million USD | 236.355% |
| Immix Biopharma, Inc. | -5468.00 USD | -5899552.524% |
| CalciMedica, Inc. | -58 Thousand USD | -556094.828% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -5084.716% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -11242.932% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 409.891% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -945.174% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -27472.051% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 11722.523% |
| Nutriband Inc. | 862.1 Thousand USD | 37519.224% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -94502.053% |
| Vor Biopharma Inc. | -3.49 Million USD | -9138.058% |
| Roivant Sciences Ltd. | 109.23 Million USD | 395.32% |
| Alkermes plc | 1.37 Billion USD | 123.467% |
| ProKidney Corp. | -3.16 Million USD | -10079.647% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -634.635% |
| Arcellx, Inc. | 108.27 Million USD | 397.928% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 4804.579% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -310.053% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -977454.545% |
| Atai Life Sciences N.V. | -5000.00 USD | -6451760.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -264626.446% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -335934.375% |
| MediciNova, Inc. | 979.7 Thousand USD | 33027.565% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -282.586% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -341069.69% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1456.858% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 231.921% |
| Biomea Fusion, Inc. | -4.2 Million USD | -7578.957% |
| RenovoRx, Inc. | - USD | Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -103962.258% |
| Geron Corporation | -123.5 Million USD | -161.203% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -6451760.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -322.391% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -13008.208% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 250.931% |
| Royalty Pharma plc | 1.79 Billion USD | 117.983% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -34181.934% |
| Imunon, Inc. | -720 Thousand USD | -44704.272% |
| BioAtla, Inc. | -103.73 Million USD | -210.99% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | -32.853% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -103627.653% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -189.544% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -33886.708% |
| 89bio, Inc. | -273 Thousand USD | -118065.934% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -360.288% |
| aTyr Pharma, Inc. | -2.38 Million USD | -13408.92% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 2689.029% |
| Viridian Therapeutics, Inc. | -1 Million USD | -31903.274% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 2481484715.385% |
| Akari Therapeutics, Plc | -4000.00 USD | -8064725.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 150.651% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 28928.686% |
| Liquidia Corporation | 14.6 Million USD | 2309.541% |
| Entera Bio Ltd. | -56 Thousand USD | -575958.929% |
| GH Research PLC | -315 Thousand USD | -102310.476% |
| Vericel Corporation | 135.57 Million USD | 337.943% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -480.631% |
| Xencor, Inc. | -85.26 Million USD | -278.364% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -145884.876% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -49648.016% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -32119.477% |
| Vaxcyte, Inc. | -75 Million USD | -330.124% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | -92.579% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 281.391% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 165780.403% |
| Portage Biotech Inc. | -54 Thousand USD | -597294.444% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -341069.69% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -85468.435% |
| OncoCyte Corporation | 413 Thousand USD | 78209.685% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -7176607.453% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -145312062.162% |
| Purple Biotech Ltd. | -196 Thousand USD | -164488.265% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -84570.079% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -1367.199% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 573.524% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 3697.157% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -253910.236% |
| United Therapeutics Corporation | 2.07 Billion USD | 115.584% |
| HilleVax, Inc. | -2.15 Million USD | -14862.57% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 486929.953% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -8083.386% |
| Pharming Group N.V. | 220.1 Million USD | 246.564% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -2149946.654% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -48192.365% |
| Pyxis Oncology, Inc. | -2 Million USD | -16029.65% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -4297610.147% |
| Savara Inc. | -44.26 Million USD | -628.826% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -393306.098% |
| Curis, Inc. | 9.81 Million USD | 3388.075% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -258412.838% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -141388.158% |
| BeiGene, Ltd. | 2.07 Billion USD | 115.518% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 669.068% |
| Erasca, Inc. | -3.73 Million USD | -8543.971% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1143117.095% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1143117.095% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -35156.066% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 4129.39% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -60085.261% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -190.29% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -8890.886% |
| Adicet Bio, Inc. | -6.09 Million USD | -5190.144% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 189.107% |
| Aditxt, Inc. | -111.66 Thousand USD | -288806.502% |
| Adagene Inc. | 18.11 Million USD | 1881.151% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 66205.123% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 304.385% |
| Compugen Ltd. | 31.45 Million USD | 1125.57% |
| Generation Bio Co. | -73.91 Million USD | -336.461% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -73719.908% |
| Invivyd, Inc. | -2.02 Million USD | -15806.953% |
| Relay Therapeutics, Inc. | -300.84 Million USD | -7.23% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -311770.879% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 434.751% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 428.212% |
| Instil Bio, Inc. | -4.75 Million USD | -6682.864% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 1438.05% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 28532.812% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1456.858% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -165914.636% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -38487.679% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 486.733% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 441331.262% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 706.811% |
| Verve Therapeutics, Inc. | -173.18 Million USD | -86.268% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -91286.119% |
| Cingulate Inc. | -582.91 Thousand USD | -55241.06% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -1040522.581% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -1537.611% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -32551.113% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -572462.209% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -501.112% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -110377.055% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -61113.093% |
| ImmunityBio, Inc. | -17.89 Million USD | -1703.203% |
| Korro Bio, Inc. | -3.63 Million USD | -8786.86% |
| Kineta, Inc. | 5.43 Million USD | 6037.659% |
| BioVie Inc. | -229.37 Thousand USD | -140538.774% |
| Codexis, Inc. | 57.33 Million USD | 662.656% |
| Celularity Inc. | 6.75 Million USD | 4875.618% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -270986.555% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 8138.699% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 637761.593% |
| Cibus, Inc. | 1.42 Million USD | 22785.865% |
| IN8bio, Inc. | -2.5 Million USD | -12798.561% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -15682.436% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 50505.156% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 141.437% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 286.518% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | -827061.538% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -16878.579% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -896.611% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 507.294% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -1425.118% |
| Moolec Science SA | -143.3 Thousand USD | -225009.382% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -662.307% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 9914.207% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -360.255% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -16968.413% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -8931046.179% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 139514.67% |
| Humacyte, Inc. | -76.55 Million USD | -321.415% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -25563.723% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -37941.627% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -262170.732% |
| Notable Labs, Ltd. | 113 Thousand USD | 285580.531% |
| Immunovant, Inc. | -231 Thousand USD | -139550.649% |
| Quantum-Si incorporated | 488 Thousand USD | 66205.123% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -1075210.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 17425.081% |
| Acasti Pharma Inc. | -11 Thousand USD | -2932563.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -157556.988% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -16375.638% |
| PepGen Inc. | -1.18 Million USD | -27146.03% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1308.888% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -390528.822% |
| Immuneering Corporation | -764.13 Thousand USD | -42116.589% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Belite Bio, Inc | -399 Thousand USD | -80750.376% |
| XOMA Corporation | 3.86 Million USD | 8455.167% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -1510.067% |
| Bionomics Limited | -434.44 Thousand USD | -74153.365% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -29936.592% |
| uniQure N.V. | 2.21 Million USD | 14664.018% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -250.382% |
| Forte Biosciences, Inc. | -9000.00 USD | -3584266.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -38533.892% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -73719.908% |
| Altimmune, Inc. | -65.37 Million USD | -393.465% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -13302.285% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -29936.592% |
| Peak Bio, Inc. | 367.76 Thousand USD | 87816.202% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 1415.847% |
| Benitec Biopharma Inc. | 108 Thousand USD | 298797.222% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -413480.769% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -26715.711% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -17605.434% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -26715.711% |
| argenx SE | 1.1 Billion USD | 129.102% |
| Immunome, Inc. | -8.9 Million USD | -3521.792% |
| Verona Pharma plc | -679.62 Thousand USD | -47366.393% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -184238.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | -13425.912% |
| CervoMed Inc. | -1.29 Million USD | -24837.095% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -6653.046% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 13155.16% |
| Moolec Science SA | -143.3 Thousand USD | -225009.382% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -78961.098% |
| Design Therapeutics, Inc. | -537 Thousand USD | -59973.184% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -75448.712% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 15132.293% |
| Achilles Therapeutics plc | -4.73 Million USD | -6718.322% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -608.248% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 750316.279% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -39144.891% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -2451587.187% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -977454.545% |
| Beam Therapeutics Inc. | -59.67 Million USD | -440.61% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 331.523% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 1597.299% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -108517.172% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -7910.679% |
| NeurAxis, Inc. | 2.15 Million USD | 15057.685% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -3272.287% |
| Lumos Pharma, Inc. | 2 Million USD | 16173.393% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 1118.969% |
| Palisade Bio, Inc. | 246 Thousand USD | 131235.366% |
| Nutriband Inc. | 862.1 Thousand USD | 37519.224% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 2391.143% |
| Neurogene Inc. | -3.26 Million USD | -9789.424% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -586432.727% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -8637.622% |
| Athira Pharma, Inc. | -969 Thousand USD | -33191.331% |
| HCW Biologics Inc. | -574.82 Thousand USD | -56020.308% |
| XOMA Corporation | 3.86 Million USD | 8455.167% |
| Nektar Therapeutics | 53.47 Million USD | 703.226% |
| Arvinas, Inc. | 71.8 Million USD | 549.294% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -286.519% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -413.888% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -100084.161% |
| Rezolute, Inc. | -36 Thousand USD | -895991.667% |
| Clene Inc. | 533 Thousand USD | 60624.015% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -25123965.421% |
| BeyondSpring Inc. | 1.75 Million USD | 18523.358% |
| Synlogic, Inc. | -1.92 Million USD | -16666.788% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -871772.973% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -4994.646% |
| Peak Bio, Inc. | 367.76 Thousand USD | 87816.202% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -1601.171% |
| Krystal Biotech, Inc. | 47.6 Million USD | 777.645% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 328.642% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 6519.761% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -12359.085% |
| MannKind Corporation | 136.19 Million USD | 336.868% |
| Ikena Oncology, Inc. | -50.49 Million USD | -538.899% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 396.463% |
| Gossamer Bio, Inc. | -4.38 Million USD | -7256.739% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -127913.095% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -6451760.0% |
| Legend Biotech Corporation | 140.92 Million USD | 328.905% |
| Mural Oncology plc | -2.56 Million USD | -12466.926% |
| Disc Medicine, Inc. | -100 Thousand USD | -322493.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 1654.365% |
| REGENXBIO Inc. | 53.02 Million USD | 708.333% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -5921.949% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -167589.669% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -18525.462% |
| Vaxart, Inc. | -60.76 Million USD | -430.904% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -122661.626% |
| Cellectis S.A. | 18 Thousand USD | 1792283.333% |
| Longeveron Inc. | 221 Thousand USD | 146069.683% |
| Repare Therapeutics Inc. | -80.07 Million USD | -302.889% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 129.515% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -24829.907% |
| Revolution Medicines, Inc. | -399.66 Million USD | 19.284% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -921594.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 658453.061% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 103.748% |
| Denali Therapeutics Inc. | -93.34 Million USD | -245.592% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1287747.818% |
| Veru Inc. | 7.56 Million USD | 4363.76% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -213537.748% |
| Cingulate Inc. | -582.91 Thousand USD | -55241.06% |
| Passage Bio, Inc. | -3.72 Million USD | -8569.524% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -2678354.002% |
| Exicure, Inc. | -1.42 Million USD | -22569.923% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -84127.937% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 12034.628% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -62823.49% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -215526.943% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -444.865% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 82604.604% |
| OmniAb, Inc. | 14.66 Million USD | 2299.448% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 1713.53% |
| Lipocine Inc. | -2.85 Million USD | -11215.805% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -17403.69% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -5554.566% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -21316.38% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 528.319% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -496196.923% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 482.691% |
| Ocugen, Inc. | -33.53 Million USD | -861.902% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -10102.182% |
| Q32 Bio Inc. | 578 Thousand USD | 55911.938% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -121633.208% |
| Alumis Inc. Common Stock | -1.28 Million USD | -25024.065% |
| Equillium, Inc. | 35.95 Million USD | 997.138% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -18798.243% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 64531.103% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -7803310.74% |
| Dominari Holdings Inc. | 2.03 Million USD | 15921.138% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -175727.787% |
| vTv Therapeutics Inc. | -13.59 Million USD | -2272.88% |
| Bio-Techne Corporation | 773.07 Million USD | 141.729% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 1962.654% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 170.009% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -27495.637% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -1245.259% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 2857.912% |
| Nkarta, Inc. | -5.86 Million USD | -5396.558% |
| BioCardia, Inc. | -7.24 Million USD | -4350.172% |
| Iterum Therapeutics plc | -1.75 Million USD | -18333.886% |